BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 25168321)

  • 1. Saccadic eye movements in juvenile variant of Huntington disease.
    Grabska N; Rudzińska M; Wójcik-Pędziwiatr M; Michalski M; Sławek J; Szczudlik A
    Neurol Neurochir Pol; 2014; 48(4):236-41. PubMed ID: 25168321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eye-head coordination in moderately affected Huntington's Disease patients: do head movements facilitate gaze shifts?
    Becker W; Jürgens R; Kassubek J; Ecker D; Kramer B; Landwehrmeyer B
    Exp Brain Res; 2009 Jan; 192(1):97-112. PubMed ID: 18807023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saccades in adult Niemann-Pick disease type C reflect frontal, brainstem, and biochemical deficits.
    Abel LA; Walterfang M; Fietz M; Bowman EA; Velakoulis D
    Neurology; 2009 Mar; 72(12):1083-6. PubMed ID: 19307542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular motor abnormalities in Huntington's disease.
    Lasker AG; Zee DS
    Vision Res; 1997 Dec; 37(24):3639-45. PubMed ID: 9425536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reflexive and voluntary saccadic eye movements as biomarker of Huntington's Disease.
    Grabska N; Wójcik-Pędziwiatr M; Sławek J; Sołtan W; Gawryluk J; Rudziński M; Szczudlik A; Rudzińska-Bar M
    Neurol Neurochir Pol; 2024; 58(3):323-330. PubMed ID: 38818957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an oculomotor biomarker of preclinical Huntington disease.
    Golding CV; Danchaivijitr C; Hodgson TL; Tabrizi SJ; Kennard C
    Neurology; 2006 Aug; 67(3):485-7. PubMed ID: 16625001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficits in saccadic eye-movement control in Parkinson's disease.
    Chan F; Armstrong IT; Pari G; Riopelle RJ; Munoz DP
    Neuropsychologia; 2005; 43(5):784-96. PubMed ID: 15721191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in cognitive control in pre-manifest Huntington's disease examined using pre-saccadic EEG potentials - a longitudinal study.
    Ness V; Bestgen AK; Saft C; Beste C
    J Huntingtons Dis; 2014; 3(1):33-43. PubMed ID: 25062763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oculomotor deficits indicate the progression of Huntington's disease.
    Hicks SL; Robert MP; Golding CV; Tabrizi SJ; Kennard C
    Prog Brain Res; 2008; 171():555-8. PubMed ID: 18718352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saccadic impairments in Huntington's disease.
    Peltsch A; Hoffman A; Armstrong I; Pari G; Munoz DP
    Exp Brain Res; 2008 Apr; 186(3):457-69. PubMed ID: 18185924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reflexive and volitional saccades: biomarkers of Huntington disease severity and progression.
    Patel SS; Jankovic J; Hood AJ; Jeter CB; Sereno AB
    J Neurol Sci; 2012 Feb; 313(1-2):35-41. PubMed ID: 22018763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of voluntary saccades and facilitation of reflexive saccades do not co-occur in Parkinson's disease.
    van Stockum S; MacAskill MR; Anderson TJ
    J Clin Neurosci; 2012 Aug; 19(8):1119-24. PubMed ID: 22705130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reflexive and voluntary saccades in Parkinson's disease].
    Yoshida H; Yamada T; Matsuzaki H
    Nippon Ganka Gakkai Zasshi; 2002 May; 106(5):281-6. PubMed ID: 12048923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal antisaccades and smooth pursuit eye movements in patients with Wilson's disease.
    Leśniak M; Członkowska A; Seniów J
    Mov Disord; 2008 Oct; 23(14):2067-73. PubMed ID: 18759342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of motor and cognitive impairment upon visually-guided saccades in Parkinson's disease.
    Macaskill MR; Graham CF; Pitcher TL; Myall DJ; Livingston L; van Stockum S; Dalrymple-Alford JC; Anderson TJ
    Neuropsychologia; 2012 Dec; 50(14):3338-47. PubMed ID: 23000134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Test-retest reliability of saccadic measures in subjects at risk for Huntington disease.
    Blekher T; Weaver MR; Cai X; Hui S; Marshall J; Jackson JG; Wojcieszek J; Yee RD; Foroud TM
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5707-11. PubMed ID: 19553607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oculomotor control in asymptomatic and recently diagnosed individuals with the genetic marker for Huntington's disease.
    Blekher TM; Yee RD; Kirkwood SC; Hake AM; Stout JC; Weaver MR; Foroud TM
    Vision Res; 2004 Oct; 44(23):2729-36. PubMed ID: 15358067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Don't look now or look away: two sources of saccadic disinhibition in Parkinson's disease?
    van Stockum S; MacAskill M; Anderson T; Dalrymple-Alford J
    Neuropsychologia; 2008 Nov; 46(13):3108-15. PubMed ID: 18674551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saccades in presymptomatic and early stages of Huntington disease.
    Blekher T; Johnson SA; Marshall J; White K; Hui S; Weaver M; Gray J; Yee R; Stout JC; Beristain X; Wojcieszek J; Foroud T
    Neurology; 2006 Aug; 67(3):394-9. PubMed ID: 16855205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociating cognitive deficits involved in voluntary eye movement dysfunctions in Parkinson's disease patients.
    Amador SC; Hood AJ; Schiess MC; Izor R; Sereno AB
    Neuropsychologia; 2006; 44(8):1475-82. PubMed ID: 16376954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.